tradingkey.logo
tradingkey.logo
Pesquisar

Inogen Inc

INGN
Adicionar à lista de desejos
6.600USD
-0.050-0.75%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
179.73MValor de mercado
PerdaP/L TTM

Mais detalhes de Inogen Inc Empresa

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Informações de Inogen Inc

Código da empresaINGN
Nome da EmpresaInogen Inc
Data de listagemFeb 14, 2014
CEOSmith (Kevin R. M)
Número de funcionários766
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 14
Endereço859 Ward Drive
CidadeGOLETA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal93111
Telefone18055620500
Sitehttps://www.inogen.com/
Código da empresaINGN
Data de listagemFeb 14, 2014
CEOSmith (Kevin R. M)

Executivos da empresa Inogen Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
74.35K
+37.77%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
74.35K
+37.77%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
37.19K
+75.50%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Ryan Peterson
Mr. Ryan Peterson
Associate Director - Investor Relations
Associate Director - Investor Relations
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
74.35K
+37.77%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
74.35K
+37.77%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
37.19K
+75.50%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Inogen Inc?

Os cinco principais acionistas de Inogen Inc são: Mr. Michael J. Bourque

Quantas instituições possuem ações da Inogen Inc (INGN)?

Em 2026Q1, 294 instituições possuíam ações da Inogen Inc, com valor de mercado aproximado de 20.74M, representando 75.89% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -3285676.00.